Medtronic Announces New Data From STOP AF Pivotal Trial

Medtronic, Inc. released new STOP AF clinical trial data showing the number of paroxysmal atrial fibrillation (AF) patients reporting AF symptoms declined by 80 percent after treatment with the Arctic Front Cardiac CryoAblation Catheter System.
centredaily